Vaccines: EU signs contract for 200 million doses of Novavax

(ANSA) - BRUSSELS, AUGUST 04 - The European Commission has announced the signing of an agreement with a pharmaceutical company to supply EU countries with up to 200 million doses of Novavax vaccine in the fourth quarter of this year and the next two years.

This was announced by the Commission itself.

   The agreement will become operational as soon as Novavax is judged "safe and effective" by the EMA, a note reads.

(HANDLE).